Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
HALOZYME THERAPEUTICS, INC. | Director | Common Stock | 20.8K | $799K | $38.49 | Apr 25, 2024 | Direct |
HALOZYME THERAPEUTICS, INC. | Director | Option to Purchase Common Stock | 8.8K | $122K | $13.87 | Apr 25, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HALO | HALOZYME THERAPEUTICS, INC. | Apr 25, 2024 | 2 | $0 | 4 | Apr 29, 2024 | Director |
HALO | HALOZYME THERAPEUTICS, INC. | May 5, 2023 | 2 | $0 | 4 | May 9, 2023 | Director |
HALO | HALOZYME THERAPEUTICS, INC. | May 5, 2022 | 1 | $0 | 4 | May 6, 2022 | Director |
HALO | HALOZYME THERAPEUTICS, INC. | Mar 24, 2022 | 0 | $0 | 3 | Mar 24, 2022 | Director |